Manulife (Manufacturers Life Insurance)’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $46.7K | Sell |
16,165
-51
| -0.3% | -$147 | ﹤0.01% | 2895 |
|
2025
Q1 | $34.9K | Buy |
16,216
+513
| +3% | +$1.1K | ﹤0.01% | 2860 |
|
2024
Q4 | $60.8K | Sell |
15,703
-458
| -3% | -$1.77K | ﹤0.01% | 2915 |
|
2024
Q3 | $106K | Sell |
16,161
-454
| -3% | -$2.97K | ﹤0.01% | 2855 |
|
2024
Q2 | $120K | Buy |
+16,615
| New | +$120K | ﹤0.01% | 2780 |
|
2019
Q1 | – | Sell |
-874
| Closed | -$52K | – | 2636 |
|
2018
Q4 | $52K | Sell |
874
-122
| -12% | -$7.26K | ﹤0.01% | 2482 |
|
2018
Q3 | $140K | Buy |
996
+904
| +983% | +$127K | ﹤0.01% | 2849 |
|
2018
Q2 | $11K | Hold |
92
| – | – | ﹤0.01% | 3869 |
|
2018
Q1 | $8K | Buy |
92
+67
| +268% | +$5.83K | ﹤0.01% | 3986 |
|
2017
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 4271 |
|
2017
Q3 | $1K | Sell |
25
-51
| -67% | -$2.04K | ﹤0.01% | 4170 |
|
2017
Q2 | $3K | Sell |
76
-376
| -83% | -$14.8K | ﹤0.01% | 4049 |
|
2017
Q1 | $26K | Buy |
452
+388
| +606% | +$22.3K | ﹤0.01% | 3485 |
|
2016
Q4 | $2K | Hold |
64
| – | – | ﹤0.01% | 4113 |
|
2016
Q3 | $3K | Hold |
64
| – | – | ﹤0.01% | 3999 |
|
2016
Q2 | $5K | Sell |
64
-910
| -93% | -$71.1K | ﹤0.01% | 3800 |
|
2016
Q1 | $74K | Buy |
974
+47
| +5% | +$3.57K | ﹤0.01% | 3176 |
|
2015
Q4 | $70 | Hold |
927
| – | – | ﹤0.01% | 3203 |
|
2015
Q3 | $355 | Buy |
927
+19
| +2% | +$7 | ﹤0.01% | 2223 |
|
2015
Q2 | $377 | Buy |
908
+429
| +90% | +$178 | ﹤0.01% | 2323 |
|
2015
Q1 | $228 | Buy |
479
+202
| +73% | +$96 | ﹤0.01% | 2636 |
|
2014
Q4 | $103 | Buy |
+277
| New | +$103 | ﹤0.01% | 3059 |
|